Figure 5 | Scientific Reports

Figure 5

From: A rationally identified panel of microRNAs targets multiple oncogenic pathways to enhance chemotherapeutic effects in glioblastoma models

Figure 5

MTT and western blotting assays on LN308 cell line with different p53 variant phenotypes. MTT assay to show the cell viability of LN308 cell lines engineered to express structurally mutant p53 proteins. Each condition was repeated in triplicates. Error bars show standard deviations. Asterisks show significant difference compared to cells treated with control NPs of the corresponding dose where, *represent p-value < 0.05, **represent p-value < 0.01, ***represent p-value < 0.001, ****represent p-value < 0.0001.

Back to article page